Clinical research company Fortrea Holdings (NASDAQ:FTRE) missed Wall Street’s revenue expectations in Q4 CY2024, with sales ...
Discover how FTRE's $7.7B backlog, CRO market growth, and focus on high-margin areas ensure long-term growth, efficiency, and ...
StockStory.org on MSN6d
Why Fortrea (FTRE) Shares Are Plunging TodayWhat Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 18.5% in the pre-market session after ...
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings tomorrow before market hours. Here’s what ...
Research analysts at William Blair cut their Q4 2025 earnings estimates for Fortrea in a research report issued to clients ...
Fortrea (NASDAQ:FTRE – Get Free Report) had its price objective lowered by investment analysts at Barclays from $25.00 to $12 ...
In a report released today, Max Smock from William Blair maintained a Hold rating on Fortrea Holdings Inc. (FTRE – Research Report). The ...
6d
Zacks Investment Research on MSNFortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Miss EstimatesFortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.19 per share a year ago.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON FORTREA HOLDINGS INC. (FTRE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On March 3, 2025, Fortrea ...
Holdings Inc trading halted, volatility trading pauseDiscover the Best Stocks and Maximize Your Portfolio: See what ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results